Therapeutic benefits of cannabinoids in the treatment of chronic pain in cancer patients            /               Benefícios terapêuticos dos canabinoides no Tratamento da dor crônica em pacientes com câncer

Roni Robson da Silva; Leandro Andrade da Silva; Andréa Ferreira Leite  Inácio; Eliseu da Costa  Campos; Diego Ferreira da  Silva; Tatiana  Silva

doi:10.9789/2175-5361.rpcfo.v14.11627

Autores/as

Roni Robson da Silva Escola de Enfermagem da Universidade de São Paulo-EE/USP https://orcid.org/0000-0001-6010-6438
Leandro Andrade da Silva Universidade Veiga de Almeida https://orcid.org/0000-0003-3213-5527
Andréa Ferreira Leite Inácio Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo-EERP/USP https://orcid.org/0000-0002-7132-4892
Eliseu da Costa Campos Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo-EERP/USP https://orcid.org/0000-0002-1670-9626
Diego Ferreira da Silva Escola de Enfermagem da Universidade de São Paulo-EE/USP https://orcid.org/0000-0001-8275-7178
Tatiana Silva Hospital de Clínicas da UFTM https://orcid.org/0000-0001-6965-2208

DOI:

https://doi.org/10.9789/2175-5361.rpcfo.v14.11627

Palabras clave:

Cannabis, Cannabis sativa, Marihuana Medicinal, Dolor crónico, Dolor de cáncer

Resumen

Objetivo: presentar el estado del arte de las publicaciones expresadas en la literatura científica mundial sobre el tema, así como identificar los beneficios terapéuticos del cannabis medicinal en el tratamiento del dolor. Método: se trata de una revisión integradora de la literatura, cuya búsqueda de datos se realizó en bibliotecas virtuales. Web of Science, Scopus, Medline, IBECS, Lilacs, Cochrane Library, Emerald Insight y Scielo de agosto a octubre de 2021. Resultados: se encontraron 367 artículos. Se seleccionaron 43 artículos para ser leídos en su totalidad y 15 cumplieron con los criterios de esta revisión. Conclusión: la evidencia muestra que, aunque cada vez más se prescribe o autoriza, el cannabis medicinal o los cannabinoides para el dolor crónico siguen siendo controvertidos para muchos médicos.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Roni Robson da Silva, Escola de Enfermagem da Universidade de São Paulo-EE/USP

Enfermeiro. Mestrando em Ciências da Saúde pela Escola de Enfermagem da Universidade de São Paulo EE-USP

Leandro Andrade da Silva, Universidade Veiga de Almeida

Enfermeiro. Pós-Doutor pelo Programa de Pós-graduação em Enfermagem da Universidade do Estado do Rio de Janeiro (PPGEnf/UERJ). Especialista em Saúde Mental e Atenção Psicossocial pela Escola Nacional de Saúde Pública Sérgio Arouca/ENSP da Fundação Oswaldo Cruz (FIOCRUZ). Professor do Curso de Graduação em Enfermagem da Universidade Veiga de Almeida (UVA).

Andréa Ferreira Leite Inácio , Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo-EERP/USP

Enfermeira. Especialista em Urgência e Emergência, Comissão de Controle de Infecção Hospitalar CCIH

Eliseu da Costa Campos , Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo-EERP/USP

Enfermeiro Oncologista. Doutorando pela Universidade de São Paulo Escola de Enfermagem de Ribeirão Preto (EERP-USP).

Diego Ferreira da Silva , Escola de Enfermagem da Universidade de São Paulo-EE/USP

Enfermeiro Assistencial na UTI Adulto do Hospital Universitário da Universidade Federal de São Paulo UNIFESP. Mestrando Escola de Enfermagem da Universidade de São Paulo-EE/USP no programa PROESA. Especialista modalidade Residência Multiprofissional em Neurologia e Neurocirurgia pela Universidade Federal de São Paulo UNIFESP.

Tatiana Silva, Hospital de Clínicas da UFTM

Enfermeira. Pós-graduada em Saúde Pública e Vigilância Sanitária, especialista em Segurança do Paciente e Gestão de riscos Assistenciais. Enfermeira Adjunta Unidade de Onco-Hematologia.

Citas

Silva RR da, Silva LA da. Psychosocial load and burnout syndrome in healthcare professionals in the fight against COVID-19 pandemic. Rev. Pesqui. (Univ. Fed. Estado Rio J., Online). [Internet]. 2021 [cited 2021 nov 18]; 13. Available from: https://doi.org/10.9789/2175-5361.rpcfo.v13.11097.

Silva RR da, Neves MP das, Silva LA da, Silva MVG, Hipolito RL, Marta CB. Consumo de drogas psicoativas em contexto de sexual entre homens gays como fator de risco para transmissão de HIV/Aids. Glob Acad Nurs. [Internet]. 2020 [acesso em 18 de novembro 2021]; 1(3). Disponível em: https://doi.org/10.5935/2675-5602.20200057.

Silva RR da, Silva LA da, Souza MVL de, Silva MVG da, Neves MP das, Vargas D, et al. Minority gender stress and its effects on mental health as a risk factor for depression in transgender persons: Literature review. Res Soc Dev. [Internet]. 2021 [cited 2021 nov 18]; 10(12): e51610313693. Available from: https://doi.org/10.33448/rsd-v10i3.13693.

Orjuela-Rojas JM, Orjuela XG, Serna SO. Medicinal cannabis: knowledge, beliefs, and attitudes of colombian psychiatrists. J cannabis Res. 2021 [cited 2021 nov 18]; 3(1). Available from: https://doi.org/10.1186/s42238-021-00083-z.

Silva IN de CJAG da. Estimativa 2020: incidência de câncer no Brasil TT - estimate/2020 ¬ cancer incidence in Brazil TT. [Internet]. 2020. p. 120. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf.

Fowler CJ. The endocannabinoid system - current implications for drug development. J. intern. med. [Internet]. 2021 [cited 2021 nov 18]; 290(1). Available from: https://dx.doi.org/10.1111/joim.13229.

Boland EG, Bennett MI, Allgar V, Boland JW. Cannabinoids for adult cancer-related pain: systematic review and meta-analysis. BMJ support. palliat. care (Online). [Internet]. 2020 [cited 2021 nov 18]; 10(1). Available from: http://dx.doi.org/10.1136/bmjspcare-2019-002032.

Kaufmann CN, Kim A, Miyoshi M, Han BH. Patterns of medical cannabis use among older adults from a cannabis dispensary in New York State. Cannabis Cannabinoid Res. [Internet]. 2020 [cited 2021 nov 18]; 0(0). Available from: http://doi.org/10.1089/can.2020.0064.

Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat. med. [Internet]. 2020 [cited 2021 nov 18]; 34(4). Available from: https://doi.org/10.1177/0269216319896955.

Daris B, Verboten MT, Knez Z, Ferk P. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn. j. basic med. sci. (Print). [Internet]. 2019 [cited 2021 nov 18]; 19(1). Available from: https://doi.org/10.17305/bjbms.2018.3532.

Tran T, Kavuluru R. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products. Int. j. drug policy. [Internet]. 2020 [cited 2021 nov 18]; 77. Available from: https://doi.org/10.1016/j.drugpo.2020.102688.

Lowe H, Toyang N, Steele B, Bryant J, Ngwa W, Nedamat K. The current and potential application of medicinal cannabis products in dentistry. Dent. j. [Internet]. 2021 [cited 2021 nov 18]; 9(9). Available from: https://doi.org/10.3390/dj9090106.

Fehniger J, Brodsky AL, Kim A, Pothuri B. Medical marijuana utilization in gynecologic cancer patients. Gynecol. Oncol. Rep. [Internet]. 2021 [cited 2021 nov 18]; 37. Available from: https://doi.org/10.1016/j.gore.2021.100820.

Argueta DA, Ventura CM, Kiven S, Sagi V, Gupta K. A balanced approach for cannabidiol use in chronic pain. Front. pharmacol. [Internet]. 2020 [cited 2021 nov 18]; 11. Available from: https://doi.org/10.3389/fphar.2020.00561.

Moher D. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. intern. med. [Internet]. 2009 [cited 2021 nov 18]; 151(4). Available from: https://doi.org/10.7326/0003-4819-151-4-200908180-00135.

Granholm A, Alhazzani W, Møller MH. Use of the GRADE approach in systematic reviews and guidelines. Br. j. anaesth. [Internet]. 2019 [cited 2021 nov 18]; 123(5). Available from: https://doi.org/10.1016/j.bja.2019.08.015.

Dzierzanowski T. Prospects for the use of cannabinoids in oncology and palliative care practice: a review of the evidence. Cancers. [Internet]. 2019 [cited 2021 nov 18]; 11(2). Available from: https://doi.org/10.3390/cancers11020129.

Bolshakova M, Bluthenthal R, Sussman S. Opioid use and misuse: health impact, prevalence, correlates and interventions. Psychol. health. [Internet]. 2019 [cited 2021 nov 18]; 34(9). Available from: https://doi.org/10.1080/08870446.2019.1622013.

Noori A, Miroshnychenko A, Shergill Y, Atefeh N, Miroshnychenko A, Shergill Y, et al. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ Open. [Internet]. 2021 [cited 2021 nov 18]; 11: e047717. Available from: https://doi.org/10.1136/bmjopen-2020-047717.

Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, et al. Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. Epidemiol. prev. [Internet]. 2017 [cited 2021 nov 18]; 41 (5-6). Available from: https://doi.org/10.19191/EP17.5-6.AD01.069.

Ananth P, Ma C, Al-Sayegh H, Kroon L, Klein V, Wharton C, et al. Provider perspectives on use of medical marijuana in children with cancer. Pediatrics [Internet]. 2018 [cited 2021 nov 18]; 141(1): e20170559. Available from: https://doi.org/10.1542/peds.2017-0559.

Braun IM, Wright A, Peteet J, Meyer FL, Yuppa DP, Bolcic-Jankovic D, et al. Medical oncologists' beliefs, practices, and knowledge regarding marijuana used therapeutically: a nationally representative survey study. J. clin. oncol. [Internet]. 2018 [cited 2021 nov 18]; 36(19). Available from: https://doi.org/10.1200/JCO.2017.76.1221.

Kim A, Kaufmann CN, Ko R, Li Z, Han BH. Patterns of medical cannabis use among cancer patients from a medical cannabis dispensary in New York State. J. palliat. med. [Internet]. 2019 [cited 2021 nov 18]; 22(10). Available from: https://doi.org/10.1089/jpm.2018.0529.

Good P, Haywood A, Gogna G, Martin J, Yates P, Greer R, et al. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC palliat. care. [Internet]. 2019 [cited 2021 nov 18]; 18(1). Available from: https://dx.doi.org/10.1186/s12904-019-0494-6.

Lee C, Round JM, Klarenbach S, Hanlon JG, Hyshka E, Dyck JRB, et al. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada. Harm reduct. j. [Internet]. 2021 [cited 2021 nov 18]; 18(1). Available from: https://doi.org/10.1186/s12954-021-00509-0.

Noori A, Busse JW, Sadeghirad B, Siemieniuk RA, Wang L, Couban R, et al. Individual opioids, and long-versus short-acting opioids, for chronic noncancer pain Protocol for a network meta-analysis of randomized controlled trials. Medicine (Baltimore). [Internet]. 2019 [cited 2021 nov 18]; 98(43). Available from: http://dx.doi.org/10.1097/MD.0000000000017647.